U.S. Professional Services Stock News

In November 2025, Eledon Pharmaceuticals presented results from its Phase 2 BESTOW trial of tegoprubart for the prevention of organ rejection in kidney transplant recipients at the American Society of Nephrology's Kidney Week Annual Meeting. Although the primary endpoint did not meet statistical significance, the drug showed a promising safety profile and higher kidney function in some key patient subgroups compared to standard tacrolimus therapy. We'll explore how tegoprubart's...

Earlier this month, Clean Energy Fuels Corp. reported third-quarter 2025 earnings with revenue of US$106.1 million, exceeding analyst expectations, while announcing expanded renewable natural gas (RNG) production and several new supply agreements with major fleet operators and infrastructure clients nationwide. The company also secured contracts for hydrogen fueling stations and highlighted commissioning of dairy RNG projects, pointing to diversification and growth in decarbonization...

Akero Therapeutics (AKRO) stock has been quietly trending higher this month, gaining roughly 16% despite little in the way of major news. Many investors are revisiting the company’s progress and recent momentum. See our latest analysis for Akero Therapeutics. Akero’s impressive 16% share price return this month builds on a strong year, with momentum clearly gaining steam. The stock has surged 92.5% year-to-date. While recent news has been quiet, long-term total shareholder returns have also...

Wondering if Gambling.com Group is a golden opportunity trading below its fair value, or if the recent turbulence has put the stock in the bargain bin? Let’s take a closer look at what is really behind the current price. Shares have slipped by 6.7% over the last week and are down a hefty 54.6% year-to-date, highlighting how much sentiment and perceived risk can shift for this stock. Ongoing discussions surrounding digital gambling legislation and increased competition in the affiliate...

SunOpta Inc. recently reported improved third quarter results, turning a profit, and raised its revenue guidance for 2025 to US$812 million–US$816 million, while also providing a 2026 revenue outlook of US$865 million–US$880 million. This upward revision in guidance, combined with year-over-year sales growth and positive earnings, highlights strengthened operations and management’s confidence in future performance despite a third quarter impairment charge. We’ll assess how SunOpta’s...

Cidara Therapeutics recently announced progress in its Phase 3 ANCHOR study for CD388, securing a US$45 million milestone payment from Janssen, a BARDA award valued up to US$339.2 million to support manufacturing, and receiving FDA Breakthrough Therapy designation. These updates highlight the growing validation and financial support behind CD388, a promising immunotherapeutic candidate for influenza prevention and serious diseases. We'll explore how the combination of clinical and funding...

Porch Group, Inc. recently reported third-quarter 2025 results, surpassing expectations with US$118.08 million in revenue, while raising its full-year adjusted EBITDA and gross profit guidance. This performance was driven by particularly strong results in the Insurance Services segment and management's emphasis on surplus growth and premium scaling, positioning the company for improved future profitability. We'll explore how the company’s upgraded financial outlook and insurance-driven...

Prelude Therapeutics (PRLD) is shaking up its strategy with news of a major exclusive option agreement with Incyte and a renewed focus on its KAT6A breast cancer program. The company is also pausing the SMARCA2 clinical effort. See our latest analysis for Prelude Therapeutics. Prelude’s string of announcements, including the Incyte partnership, SMARCA2 pause, and executive change, has made for a volatile stretch, with the stock tumbling 25% over the last week alone. Share price momentum...

Neptune Insurance Holdings (NP) has caught investor attention this week, with shares closing at $26.86 and posting a 6% gain for the day. The stock’s recent move stands out against a backdrop of mixed performance within the insurance sector. See our latest analysis for Neptune Insurance Holdings. With a 1-day share price return of 6.2% and a year-to-date gain of 8.3%, Neptune Insurance Holdings is showing signs of renewed momentum following a modest dip over the past month. The latest uptick...

Curious if Gogo is undervalued or just misunderstood? You are not alone in wondering if now could be a smart time to look closer at the stock. The share price has taken a hit lately, dropping 16% in just the past week and sliding nearly 17% over the last month, putting some growth-watchers on alert for both risk and potential upside. One of the drivers behind these moves is the recent announcement about Gogo's partnership expansions in inflight connectivity, which has grabbed the attention...

Chart Industries reported its third quarter 2025 earnings on October 29, 2025, showing sales of US$1.10 billion but moving from net income of US$69 million to a net loss of US$138.5 million compared to the same period last year. Despite higher revenues, the company's earnings update revealed a shift to losses, with losses per share replacing the previous year's profits. We'll explore how the shift from profit to net loss may shape the outlook for Chart Industries' investment...

Alexander & Baldwin, Inc. recently amended its US$450 million revolving credit facility, adding a new term loan facility of up to US$200 million, and raised its 2025 earnings guidance to a range of US$0.95 to US$1 per diluted share. These developments point to a focus on both financial flexibility and growth opportunities, particularly as the company actively searches for acquisitions in Hawaii’s competitive investment market. Let's examine how the creation of this new term loan facility...

Alpha and Omega Semiconductor recently released its first quarter earnings for the period ended September 30, 2025, reporting sales of US$182.5 million and a reduced net loss of US$2.12 million compared to the prior year. In addition to improved loss metrics, the company provided revenue guidance of approximately US$160 million, plus or minus US$10 million, for the upcoming quarter and expects interest income to exceed interest expense by US$1 million. We'll explore how the company's...

Heritage Insurance Holdings (HRTG) just announced its third quarter earnings, showing a sharp jump in both net income and earnings per share compared to last year, even though revenue growth was only modest. See our latest analysis for Heritage Insurance Holdings. Investors have clearly taken notice of Heritage Insurance Holdings’ remarkable turn in profitability, as the share price has soared 127.91% year-to-date and delivered a 140.09% total return over the past twelve months. Momentum has...

SelectQuote, Inc. ( NYSE:SLQT ) shareholders might be concerned after seeing the share price drop 18% in the last week...

Market forces rained on the parade of Zai Lab Limited ( NASDAQ:ZLAB ) shareholders today, when the analysts downgraded...

WW International, Inc. ( NASDAQ:WW ) shareholders are no doubt pleased to see that the share price has bounced 27% in...

NeuroPace, Inc. recently reported earnings for the third quarter and nine months ended September 30, 2025, highlighting third-quarter sales of US$27.35 million and a net loss of US$3.5 million, both reflecting improvement over the previous year. The company also reduced its basic loss per share and continued to increase total sales year-to-date, indicating ongoing progress in narrowing losses while expanding revenue. We'll examine how NeuroPace's stronger sales growth and reduced losses may...

It's been a mediocre week for Recursion Pharmaceuticals, Inc. ( NASDAQ:RXRX ) shareholders, with the stock dropping 18...

It's been a sad week for Rhythm Pharmaceuticals, Inc. ( NASDAQ:RYTM ), who've watched their investment drop 12% to...

We'd be surprised if Fortive Corporation ( NYSE:FTV ) shareholders haven't noticed that the Senior VP & Chief People...

Tactile Systems Technology recently reported strong third quarter results, raising its full-year 2025 revenue guidance to a new range of US$317 million to US$321 million and announcing a US$25 million share repurchase program, all following the release of positive long-term clinical data for Flexitouch® Plus in head and neck cancer-related lymphedema. This combination of robust financial performance, increased management confidence through buybacks, and clinically meaningful R&D progress is...

As the U.S. stock market grapples with valuation concerns and tech sector pressures, investors are keenly observing insider ownership as a potential indicator of confidence in growth companies. In this environment, stocks with significant insider ownership may offer insights into management's belief in the company's long-term prospects and resilience amidst market volatility.

As the U.S. market faces a challenging period with tech stocks under pressure and major indices experiencing losses, investors are exploring alternative opportunities to diversify their portfolios. Penny stocks, though often seen as remnants of past market trends, continue to offer potential for growth when backed by strong financials. This article will explore three promising penny stocks that stand out for their financial resilience and potential to deliver value in today's uncertain...